Oman vs Sri Lanka: Previously treated cases tested for RR-/MDR-TB
Oman
100.0%
in 2024
Sri Lanka
100.0%
in 2024
Oman rank
1st
Sri Lanka rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Oman
- Sri Lanka
How they compare
Oman currently reports 100.0% against 100.0% in Sri Lanka, a difference of 0.0%.
The two have swapped places 7 times across 18 shared years of data; in 2005 it was Oman ahead.
Oman ranks 1st and Sri Lanka ranks 1st of 180 countries.
Oman has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Oman | Sri Lanka | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 86.0% | 14.0% | Oman |
| 2010s | 96.9% | 85.6% | 11.3% | Oman |
| 2020s | 100.0% | 76.7% | 23.3% | Oman |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Oman or Sri Lanka?
- Oman, at 100.0% against 100.0% in Sri Lanka as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Oman and Sri Lanka?
- 0.0%, with Oman ahead.
- How many years of comparable data are there for Oman and Sri Lanka?
- 18 years are reported by both, from 2005 to 2024.
- How do Oman and Sri Lanka rank globally for previously treated cases tested for rr-/mdr-tb?
- Oman ranks 1st and Sri Lanka ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.